Volume 18, Number 2—February 2012
CME ACTIVITY - Research
Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010
|Calculation||A. Patients with campylobacteriosis
||B. Patients hospitalized for campylobacteriosis
||C. Patients hospitalized for GBS
||D. Patients hospitalized for GBS and campylobacteriosis‡
|Age, y||Age, y||p value for age compared with A§||Age, y||p value for age compared with B§||Age, y||p value for age compared with C§|
*GBS, Guillain-Barré syndrome.
‡Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
§Means compared with Student t-test medians compared with median 2-sample test.
Page created: January 26, 2012
Page updated: January 26, 2012
Page reviewed: January 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.